Clinical Trial Update: Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis

View source ↗

Summary

An in vitro study comparing the release kinetics of platelet-rich fibrin (PRF) versus GEM21S, with and without bone substitutes, in a bone loss model. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss

Drugs mentioned

• GEM21S (GEM21S bone graft substitute)
• PRF (Platelet-rich fibrin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Bone Loss | Status: ACTIVE_NOT_RECRUITING